Skip to main content

VVOS

Vivos Therapeutics, Inc.

Company with tickers: VVOS

CIK
1716166
CUSIP
92859E207
Shares Outstanding
13,894,600
13F Activity (30d)
17 filings 15 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 24
Total Value: $2,150,377
Total Shares: 1,822,365

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 24 13F filers · Δ vs Dec 31, 2025
Top Holder
61.2%
Dec 2023 → Mar 2026 · range 20.4% – 76.0%
+15.0 pts
Top 5
86.1%
Dec 2023 → Mar 2026 · range 71.1% – 98.4%
+0.9 pts
Top 10
94.7%
Dec 2023 → Mar 2026 · range 94.7% – 99.9%
−4.5 pts
HHI
4,033
Dec 2023 → Mar 2026 · range 1,377 – 5,957
Highly concentrated +1,387

Quarterly Activity

vs Dec 31, 2025
New
8
Increased
3
Decreased
2
Sold Out
3
Unchanged
11
Holder count: +5
Institutional value: +61.0%
Shares held: +176.9%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 24 of 24
Export CSV
Holder Value (USD) % of 13F Shares Open